Fostering Antibiotic Development through Impact Funding

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Development

Background:

• Antimicrobial resistance (AMR) poses a significant global health threat.
• The development of new antibiotics is essential to combat rising AMR.
• Economic challenges, including low return on investment, hinder antibiotic research and development.

Purpose of the Study:

• To introduce the REPAIR Impact Fund as a solution to the financial obstacles in anti-infective development.
• To stimulate continued innovation in antibiotic research.
• To bridge the gap until market structures incentivize commercial investment in anti-infectives.

Main Methods:

• The REPAIR Impact Fund provides financial support for anti-infective research.
• The fund aims to foster innovation by addressing the return on investment challenges.
• It operates until sustainable market-based incentives are established.

Main Results:

• The fund is designed to ensure the continuity of critical antibiotic research.
• It aims to mitigate the negative impact of poor commercial viability on drug development.
• The initiative seeks to foster a more robust pipeline of new anti-infective agents.

Conclusions:

• The REPAIR Impact Fund is a strategic initiative to address the economic crisis in antibiotic development.
• It serves as a crucial mechanism to maintain innovation in the face of market failures.
• The fund's ultimate goal is to ensure a sustainable supply of new antibiotics to combat antimicrobial resistance.